Walker Neal
SEC CIK 1604457 · EDGAR
BoughtSold
Most active insiders at ACRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Leonard Braden Michael | 10% | — | $1.36M |
| 2 | Kolbeck Roland Wilhelm | CSO | — | — |
| 3 | Hall Jesse Wayne | Chief Medical Off | — | — |
| 4 | Davis Hugh M. | Pres, COO, Dir | — | — |
| 5 | Balthaser Kevin | CFO | — | — |
| 6 | Loerop James | Chief Business Off | — | — |
| 7 | Humphries William D. | Dir | — | — |
| 8 | Molineaux Christopher P. | Dir | — | — |
| 9 | Walker Neal | CEO, Dir | — | — |
| 10 | Mehra Anand | Dir | — | — |
Transactions 47
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-05 | 2026-02-03 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Dir | M - OptEx | — | +63.5K | 1.56M | +4% | — |
| D | 2026-02-05 | 2026-02-03 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Dir | F - Tax | $3.47 | -18.6K | 1.54M | -1% | -$64.6K |
| D | 2026-01-05 | 2026-01-02 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Dir | M - OptEx | — | +29.1K | 1.51M | +2% | — |
| D | 2026-01-05 | 2026-01-02 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Dir | F - Tax | $2.88 | -9,952 | 1.50M | -0.7% | -$28.7K |
| D | 2025-05-05 | 2025-05-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Dir | M - OptEx | — | +9,467 | 1.48M | +0.6% | — |
| D | 2025-05-05 | 2025-05-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Dir | F - Tax | $1.38 | -2,975 | 1.48M | -0.2% | -$4,106 |
| D | 2025-04-03 | 2025-04-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Dir | F - Tax | $1.48 | -3,042 | 1.47M | -0.2% | -$4,502 |
| D | 2025-04-03 | 2025-04-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Dir | M - OptEx | — | +9,467 | 1.48M | +0.6% | — |
| D | 2025-03-04 | 2025-03-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Dir | F - Tax | $1.99 | -3,277 | 1.47M | -0.2% | -$6,521 |
| D | 2025-03-04 | 2025-03-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Dir | M - OptEx | — | +9,466 | 1.47M | +0.6% | — |
| D | 2025-02-04 | 2025-02-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO, Dir | F - Tax | $2.48 | -3,559 | 1.46M | -0.2% | -$8,826 |
| D | 2025-02-04 | 2025-02-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO, Dir | M - OptEx | — | +9,467 | 1.46M | +0.7% | — |
| DM | 2025-01-03 | 2025-01-01+ | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO, Dir | F - Tax | $2.48 | -17.4K | 1.44M | -1% | -$43.2K |
| DM | 2025-01-03 | 2025-01-01+ | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO, Dir | M - OptEx | — | +38.6K | 1.47M | +3% | — |
| D | 2024-12-06 | 2024-12-04 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO, Dir | M - OptEx | $1.52 | +118.8K | 1.50M | +9% | +$180.6K |
| D | 2024-12-06 | 2024-12-04 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO, Dir | F - Tax | $3.76 | -68.3K | 1.43M | -5% | -$257.0K |
| D | 2024-12-03 | 2024-12-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO, Dir | M - OptEx | — | +9,466 | 1.39M | +0.7% | — |
| D | 2024-12-03 | 2024-12-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM CEO, Dir | F - Tax | $4.07 | -2,721 | 1.38M | -0.2% | -$11.1K |
| D | 2024-11-05 | 2024-11-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | F - Tax | $2.09 | -2,721 | 1.38M | -0.2% | -$5,687 |
| D | 2024-11-05 | 2024-11-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | M - OptEx | — | +9,467 | 1.38M | +0.7% | — |
| D | 2024-10-03 | 2024-10-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | M - OptEx | — | +9,467 | 1.37M | +0.7% | — |
| D | 2024-10-03 | 2024-10-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | F - Tax | $1.18 | -2,722 | 1.37M | -0.2% | -$3,212 |
| D | 2024-09-04 | 2024-09-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | M - OptEx | — | +9,466 | 1.37M | +0.7% | — |
| D | 2024-09-04 | 2024-09-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | F - Tax | $1.18 | -2,722 | 1.36M | -0.2% | -$3,212 |
| D | 2024-08-13 | 2024-08-09 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | M - OptEx | $0.72 | +43.5K | 1.36M | +3% | +$31.4K |
| D | 2024-08-05 | 2024-08-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | M - OptEx | — | +9,467 | 1.32M | +0.7% | — |
| D | 2024-08-05 | 2024-08-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | F - Tax | $1.32 | -2,722 | 1.31M | -0.2% | -$3,593 |
| D | 2024-07-03 | 2024-07-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | M - OptEx | — | +9,467 | 1.31M | +0.7% | — |
| D | 2024-07-03 | 2024-07-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | F - Tax | $1.15 | -2,722 | 1.31M | -0.2% | -$3,130 |
| D | 2024-06-04 | 2024-06-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | F - Tax | $1.03 | -2,722 | 1.30M | -0.2% | -$2,804 |
| D | 2024-06-04 | 2024-06-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | M - OptEx | — | +9,466 | 1.30M | +0.7% | — |
| D | 2024-05-03 | 2024-05-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | F - Tax | $1.26 | -2,784 | 1.29M | -0.2% | -$3,508 |
| D | 2024-05-03 | 2024-05-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | M - OptEx | — | +9,467 | 1.30M | +0.7% | — |
| D | 2024-04-03 | 2024-04-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | F - Tax | $1.26 | -3,224 | 1.29M | -0.3% | -$4,062 |
| D | 2024-04-03 | 2024-04-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | INTERIM Pres AND CEO, Dir | M - OptEx | — | +9,467 | 1.29M | +0.7% | — |
| D | 2024-03-05 | 2024-03-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Interim Pres, Dir | M - OptEx | — | +9,466 | 1.28M | +0.7% | — |
| D | 2024-03-05 | 2024-03-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | CEO, Interim Pres, Dir | F - Tax | $1.24 | -3,223 | 1.28M | -0.3% | -$3,997 |
| D | 2023-08-24 | 2023-08-22 | ALDX | Aldeyra Therapeutics, Inc. | Walker Neal | Dir | M - OptEx | $0.55 | +9,604 | 15.9K | +154% | +$5,282 |
| DM | 2023-03-03 | 2023-03-01+ | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Dir | M - OptEx | — | +156.7K | 1.27M | +14% | — |
| DM | 2023-03-03 | 2023-03-02+ | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Dir | S - Sale+OE | $12.50 | -59.2K | 1.27M | -4% | -$740.7K |
| M | 2023-02-03 | 2023-02-01+ | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Dir | S - Sale | $16.67 | -30.0K | 1.18M | -2% | -$500.0K |
| M | 2023-01-04 | 2023-01-03+ | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Dir | S - Sale | $15.12 | -40.0K | 1.22M | -3% | -$604.7K |
| M | 2022-04-25 | 2022-04-21+ | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Pres, CEO, Dir | S - Sale | $15.15 | -70.0K | 1.27M | -5% | -$1.06M |
| 2022-03-14 | 2022-03-11 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Pres, CEO, Dir | S - Sale | $15.91 | -56.3K | 1.32M | -4% | -$895.8K | |
| DM | 2022-03-03 | 2022-03-01+ | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Pres, CEO, Dir | M - OptEx | — | +132.7K | 1.35M | +11% | — |
| 2022-02-11 | 2022-02-09 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Pres, CEO, Dir | S - Sale | $12.66 | -3,595 | 1.24M | -0.3% | -$45.5K | |
| D | 2022-02-03 | 2022-02-01 | ACRS | Aclaris Therapeutics, Inc. | Walker Neal | Pres, CEO, Dir | M - OptEx | — | +10.8K | 1.24M | +0.9% | — |
Purchase Sale Sale after option exercise All abbreviations